ACST-2 Ophthalmic sub-study Athanasios D. Giannoukas MD, MSc(Lond.), PhD(Lond.), FEBVS Professor of Vascular Surgery Chairman, Dept. of Vascular Surgery,

Slides:



Advertisements
Similar presentations
Differences between CAS and CEA in the pathophysiological mechanism of procedural stroke GJ de Borst Department of Vascular Surgery.
Advertisements

Ghanem et al., J Am Coll Cardiol 2010;55:1427–32..
ECST-2: An update Martin M Brown Professor of Stroke Medicine UCL Institute of Neurology Queen Square, London ACST-2 Collaborators.
St Luke’s- Hospital Carotid Intervention Position Statement1.
SVS Clinical Research Priorities: Carotid Disease John J Ricotta MD FACS.
Is Carotid Stenting an Option for Treatment of Carotid Stenosis? Joint Hospital Surgical Grand Round WH WONG Queen Mary Hospital.
Dr Amer Jafar. Early Dementia After First-Ever Stroke From 1985 to 2008, overall first-ever strokes occurring within the population of the city of Dijon,
The INSIGHT study - Reliable blood pressure control and additional benefits for hypertensive patients Anthony M Heagerty Department of Medicine Manchester.
J. Stephen Huff, MD, FACEP Transient Ischemic Attack Patient Update: The Optimal Management of Emergency Department Patients With Suspected Cerebral Ischemia.
Stenting and Angioplasty with Protection in Patients at High-Risk for Endarterectomy Presented by Jay Yadav, MD on behalf of the SAPPHIRE Investigators.
Stroke Issues & prevention. Agenda  Impact of Stroke –Definitions –Epidemiology –Risk factors  Management of Stroke –Acute management –Primary & Secondary.
Journal Club Ani Balmanoukian and Peter Benjamin November 9, 2006 Journal Club Ani Balmanoukian and Peter Benjamin November 9, 2006.
Carotid Endarterectomy versus Stenting: Where do we stand today? Vascular Conference March 23, 2010.
Endovascular Management of Intracranial and Extracranial Atherosclerosis Rishi Gupta, MD Associate Professor of Neurology, Neurosurgery, and Radiology.
Hind Alnajashi. C AROTID ARTERY ANATOMY Common carotid artery Aortic arch Internal carotid MCA ACA Ophthalmic artery. Cervical segment Petrous segment.
Consultant Neurologist,
Simultaneous Coronary Artery Bypass and Carotid Endarterectomy Ye zhidong, Liu Peng Department of Cardiovascular Surgery China-Japan Friendship Hospital.
Rashad MAHMUDOV Central Hospital of Oilworkers, Baku-Azerbaijan
What Is Peripheral Vascular Disease? Daniel B. Walsh, M.D. Professor of Surgery, Section of Vascular Surgery Vice-Chair, Department of Sugery Dartmouth-Hitchcock.
Professor Jean – Baptiste Ricco Hospital Jean Bernard, Poitiers, France Hospital Jean Bernard, Poitiers, France.
Carotid Artery Stenosis: Stenting vs. Endarterectomy Városmajor Study. L. Entz,, E.Dósa, K. Hüttl. Department of Cardiovascular Surgery, Semmelweis University,
Carotid artery stenting for carotid artery stenosis Dr. Nikolaos Melas, PhD Vascular and Endovascular Surgeon Military Doctor Associate in 1st department.
Endarterectomy versus Stenting in Patients with Symptomatic Severe Carotid Stenosis Dr. Quan, Dr. Mirhashemi, Dr. Chiang N Engl J Med 2006; 355:
1 Statin treatment is associated with improved prognosis in patients with AF-related stroke G. Ntaios, V. Papavasileiou, K.Makaritsis, A.Karagiannaki,
‘STROKE’ February 2011 Dr Amer Jafar ABHB/Gwent. Decreased Kidney Function  Chronic kidney disease is an important risk factor for development and progression.
Epidemiology in HK  Stroke is major cause of morbidity and mortality around the world  4th cause of mortality in HK resulting in >3000 deaths every.
Cerebral Angiography for the Treatment of Cerebral Ischemia.
ProximAl pRotection with the MO.MA device dUring caRotid stenting proximAl pRotection with the MO.MA device dUring caRotid stenting Barry T. Katzen MD.
Adult Medical-Surgical Nursing Neurology Module: Cerebrovascular Disease I (TIA)
Atherosclerotic Disease of the Carotid Artery Atherosclerosis is a degenerative disease of the arteries resulting in plaques consisting of necrotic cells,
CHU C A E N EVA-3S Inferences and future directions Jacques Theron, MD Martial Hamon, MD.
New embolic cerebral lesions detected with diffusion-weighted imaging after carotid artery and intracranial stent placement YH Chen, CJ Chen, DC Chen,
: PROFI : A Prospective, Randomized Trial of Proximal Balloon Occlusion vs. Filter Embolic Protection in Patients Undergoing Carotid Stenting Klaudija.
Carotid Disease – Stent vs Surgery vs Medical Therapy? Mehdi H. Shishehbor, DO, MPH, PhD Director, Endovascular Services Interventional Cardiology & Vascular.
VASIL VELCHEV ST. ANNA HOSPITAL, SOFIA. Conflict of interest:
CAROTID ARTERY ENDARTHERECTOMY &INTERVENTION
ACUTE STROKE Alexa Lauch IMG 310 Summer Semester 2016.
Stents implantation to treat carotid lesions Lessons learned in the last 17 years Hugo Londero MD Córdoba-Argentina.
Dr. Quan, Dr. Mirhashemi, Dr. Chiang
(p for noninferiority = 0.01)
John P. A. Ioannidis (age 50) Stanford School of Medicine, Athens Graduate, former chairman Department of Hygiene and Epidemiology, University of Ioannina.
John. J Ricotta, MD, FACS Professor of Surgery, Georgetown University
“The Brain Stress Test”
The Importance of Adequately Powered Studies
Carotid Artery Stenosis
Heart Valve Thrombosis & Neuro-Outcomes
Damian Gimpel Waikato Cardiothoracic Unit Journal Club
CQC Amit Gossain.
Larissa Registry on CAS and CEA:
L. Nelson Hopkins, MD DISCLOSURES Consulting Fees
Slow-Flow During Carotid Intervention
Pooled Analysis of VA, ACAS, ACST-1 & GALA Trials
Comparison of carotid endarterectomy and stenting in real world practice using a regional quality improvement registry  Brian W. Nolan, MD, MS, Randall.
Section 5: Intervention and drug therapy
American College of Cardiology Presented by Dr. Stephan Windecker
Median total new lesion volume
Compare-Acute Trial design: STEMI patients undergoing primary PCI were randomized to fractional flow reserve (FFR)-guided complete revascularization (n.
Dr. PJ Devereaux on behalf of POISE Investigators
Silent cerebral events in asymptomatic carotid stenosis
Status Update from ACST-2
Dr. PJ Devereaux on behalf of POISE Investigators
John Ochsner Heart and Vascular Institute
ISAR-LEFT MAIN: A Randomized Clinical Trial on Drug-Eluting Stents for Unprotected Left Main Lesions J. Mehilli, MD Deutsches Herzzentrum Technische.
ISAR-LEFT MAIN: A Randomized Clinical Trial on Drug-Eluting Stents for Unprotected Left Main Lesions J. Mehilli, MD Deutsches Herzzentrum Technische.
Diagnosis and Invasive Management of Carotid Atherosclerotic Stenosis
Long-term Outcomes of Carotid Endarterectomy Versus Stenting: A 12-Year Multicenter Observational Analysis of 14,464 Patients  Mohamad A. Hussain, Muhammad.
M. Hassan Murad, MD, MPH, David N. Flynn, BS, Mohamed B
Michael J. Gough, ChM, FRCS  Journal of Vascular Surgery 
Transcarotid Artery Revascularization versus Transfemoral Carotid Artery Stenting for Treatment of Carotid Artery Stenosis Patric Liang, MD; Marc L.
Craig R. Narins, MD, Karl A. Illig, MD  Journal of Vascular Surgery 
Presentation transcript:

ACST-2 Ophthalmic sub-study Athanasios D. Giannoukas MD, MSc(Lond.), PhD(Lond.), FEBVS Professor of Vascular Surgery Chairman, Dept. of Vascular Surgery, University Hospital of Larissa Faculty of Medicine, School of Health Sciences, University of Thessaly, Greece

Carotid artery stenting (CAS) has emerged as an alternative therapeutic option to carotid endarterectomy (CEA) for the management of patients with carotid artery stenosis.

Several multicentre randomized controlled trials (RCTs) have compared the efficacy of CAS vs. CEA The outcomes that have been consistently evaluated are transient ischemic attack (TIA), stroke and death and myocardial infarction

Brain micro-embolisation Brain micro-embolisation is less in CEA as compared to CAS with distal filter protection devices or flow-reversal Gupta N et al. JVS 2011;53: Tedesco MM et al. JVS 2007;46:

CAS is associated on TCD with: Particulate macro-embolisation Massive air embolisation Multiple micro-embolisation All causing reduction in middle cerebral blood flow Along with the presence of pre-procedural brain infarcts may predict patients at high-risk of adverse effects Ackerstaff R et al. JVS 2005;41: Brain micro-embolisation

Retinal embolization during CAS is not uncommon, and it occurs in both protected and unprotected procedures (detected by fundoscopy only). Most retinal emboli are clinically silent (visual field testing). Vos JA et al. CVIR 2010;33:714-9 Ophthalmic insult/ embolisation

Objectives The effects of Ophthalmic insult after carotid interventions (CAS or CEA) have never been investigated in a systematic manner In respect to asymptomatic disease in which the difference in the usually investigated outcomes (Stroke, TIA, MI, death) between CAS and CEA may be marginal

Visual acuity and visual function are important parameters of the quality of life of elderly patients Anxiety and depression may often accompany diseases of the eye and conditions associated with visual dysfunction Zhou C et al. Psychosom Res 2013;75:75-82 Thus, eye-related quality of life (temporary or permanent blindness resulting from embolization of atherosclerotic debris into the ophthalmic artery) is an important denominator in asymptomatic patients undergoing carotid revascularization Rationale of the Sub-study

ACST-2 represents a unique opportunity to initiate an Ophthalmic ACST-2 substudy to investigate and compare the effects of CAS vs. CEA on the ophthalmic circulation and visual function Rationale of the Sub-study

Aim To investigate the insult of the ophthalmic circulation and the outcome in visual function in patients randomised in ACST-2 Trial Ophthalmic embolisation and visual outcome may be important surrogate end- points on which CAS and CEA may be evaluated in asymptomatic carotid disease

Methods Patients recruited for ACST-2 Trial will be subjected to: 1-3 days prior to intervention Visual field testing Colour flow Doppler assessment of OA and RA Bilateral Fundoscopy with a digital photography Bilateral Fluoroscein angiography (optional)

2-3 days after intervention Colour flow Doppler assessment of OA and RA Bilateral Fundoscopy with a digital photography Bilateral Fluoroscein angiography (optional) 6 months after intervention Visual field testing Colour flow Doppler assessment of OA and RA Methods

Financial aspects Difficult to adapt to all health care systems in Europe In Greece Visual field testing (=20 euros) along with fundoscopy and digital photography = 70 euros Fluoroscein angiography = 150 euros OA and RA Doppler imaging = 50 euros

1 st assessment = 270 euros (without FA = 120 euros) 2 nd assessment = 250 euros (without FA = 100 euros) 3 rd assessment = 70 euros Full total cost / patient = 590 euros (without FA = 290 euros) 1 Brain MRI = 237 euros Financial aspects

Numbers needed  Difficult to make power analysis due to lack of large scale observational studies  Arguably based on brain embolisation data we assume that equally Retinal embolisation will be common phenomenon  Probably 100 pts in each intervention arm (CEA vs CAS) will suffice  Interim analysis and power calculation will be undertaken when 50 pts will be in each arm

Thanks for the attention